← Back to Search

Skin Hydration Sensor for Sickle Cell Disease

N/A
Recruiting
Led By Enrico Novelli, MD
Research Sponsored by Enrico M Novelli
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosis of Sickle Cell Disease (genotypes SS, SC, Sß-thalassemia, SD, SOArab)
Participants must be ≥12-years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at a regularly scheduled clinical appointment, approximately 2 hours
Awards & highlights

Study Summary

This trial will test a new sensor to see if it can accurately measure hydration levels in patients with sickle cell disease. The sensor could be used to help guide hydration therapy for these patients.

Who is the study for?
This trial is for individuals aged 12 or older who have been diagnosed with Sickle Cell Disease, including various genotypes like SS, SC, and others. Participants must be able to give legal consent to all study procedures. Those under 12 or currently in other clinical trials for experimental therapies cannot join.Check my eligibility
What is being tested?
The trial is testing a new skin hydration sensor designed to accurately assess hydration levels in patients with Sickle Cell Disease. The goal is to see if this sensor can work as an easy-to-use device at the point of care and help guide proper hydration therapy.See study design
What are the potential side effects?
Since the intervention involves a non-invasive skin hydration sensor, there are no direct side effects expected from its use. However, any discomfort or issues related to wearing the device will be monitored.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with Sickle Cell Disease.
Select...
I am 12 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at a regularly scheduled clinical appointment, approximately 2 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and at a regularly scheduled clinical appointment, approximately 2 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Clinical dehydration assessments in SCD participants
Dermal water content measurements after fluid resuscitation in SCD participants with VOC or VOE
Dermal water content measurements before fluid resuscitation in SCD participants with VOC or VOE
+16 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Skin Hydration SensorExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Enrico M NovelliLead Sponsor
1 Previous Clinical Trials
20 Total Patients Enrolled
Enrico Novelli, MDPrincipal InvestigatorUniversity of Pittsburgh
1 Previous Clinical Trials
226 Total Patients Enrolled

Media Library

Skin Hydration Sensor Clinical Trial Eligibility Overview. Trial Name: NCT05210114 — N/A
Sickle Cell Disease Research Study Groups: Skin Hydration Sensor
Sickle Cell Disease Clinical Trial 2023: Skin Hydration Sensor Highlights & Side Effects. Trial Name: NCT05210114 — N/A
Skin Hydration Sensor 2023 Treatment Timeline for Medical Study. Trial Name: NCT05210114 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are currently enrolled in this research experiment?

"Affirmative. Clinicaltrials.gov indicates that the trial, which was initially posted on January 21st 2022 and recently updated April 6th 2022, is actively searching for 30 patients from a single participating site."

Answered by AI

Is enrollment open for this research project?

"According to the clinicaltrials.gov record, this trial is actively seeking participants. The initial post was on January 21st 2022 and it has been recently refreshed on April 6th 2022."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Cutaneous Hydration Assessment in SCD
Enrico M Novelli 2022. "Cutaneous Hydration Assessment in SCD". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05210114.
All > Sickle Cell Anemia
~5 spots leftby Oct 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top